Injectable Drug Delivery Market 2022
The Injectable Drug Delivery Market is expected to witness a strong In Upcoming Years. The ongoing trend speaks of digital transformation. In other words, it’s about the provision of digital solutions being tabled all across. The big thing is that the key stakeholders can’t afford to keep digital technology in a silo. Unification is the need of the hour so that anytime-anywhere access is possible. The enterprise is slated to move with the same mindset in the forecast period.
The global injectable drug delivery market was valued at US$ 30.5 Bn in 2022, and is expected to exhibit a CAGR of around 9% during the forecast period (2022–2031).
Request for Free Sample Report of “Injectable Drug Delivery” Market @ https://www.persistencemarketresearch.com/samples/3774
Over the years, there has been a rise in the demand for convenient and efficient drug delivery systems for patients that rely on prescription drugs on a regular basis. This creates a lucrative opportunity for pharmaceutical manufacturers all over the world to develop sophisticated, easy-to-use, and effective injectable drug delivery devices. Moreover, rise in the prevalence of chronic diseases such as diabetes, cancer, and rheumatoid arthritis are likely to fuel the growth of the injectable drug delivery market during the forecast period.
Key Players:
The report has profiled some of the important players prevalent in the global like – Eli Lilly and Company, Biocon, Becton, Dickinson & Company, West Pharmaceutical Services, Inc., and Johnson & Johnson and more.
This report covers the sales volume, price, revenue, gross margin, manufacturers, suppliers, distributors, intermediaries, customers, historical growth and future perspectives in the Injectable Drug Delivery Market.
Key Takeaways of Injectable Drug Delivery Market Study
- Insulin pens contributed the most share to the injectable drug delivery market in 2018, due to the rising prevalence of diabetes in developing countries.
- Non-smart injector technology accounted for a prominent share in the global injectable drug delivery market in 2018, due to increase in the adoption of advanced technology and rising demand for smartphone-integrated products.
- Rise in the demand for connected devices and the high cost of such devices offer growth opportunities for manufacturers of reusable injectable drug delivery devices.
- Diabetes indication is expected to continue to hold a prominent position in the injectable drug delivery market throughout the forecast period.
- Increase in the number of pharmaceutical manufacturers has contributed to the dominance of North America in the global injectable drug delivery market.
- Attributed to growing awareness regarding various diseases such as cancer and diabetes, East Asia is expected to register notable growth opportunities for the injectable drug delivery market.
“Smart injectable drug delivery devices not only improve patient compliance to treatment but also collect extensive data that is valuable for future research. Rising demand for connected injectable drug delivery devices will offer significant growth opportunity for the injectable drug delivery market,” says a PMR analyst.
Request For Customization @ https://www.persistencemarketresearch.com/request-customization/3774
Trends in Smart Injectable Drug Delivery Technologies
There are many research and pipeline products that will have the ability to connect with smartphones and trackers. However, current smart products are predominantly available as reusable devices. This is attributed to the current state of technology that requires further advancements to apply to disposable products. According to a number of studies and key opinion leaders in the industry, there are a number of factors that limit disposable injectable drug delivery devices from being integrated with smart/connecting technologies. Some of these factors include high cost of Bluetooth integration, low range connectivity with NFC, and lack of power source for connectivity. Thus, although disposable injectable drug delivery will continue holding a larger share throughout the forecast period,reusable injectable drug delivery devices have the potential to grow at a relatively faster rate, at least in the first five years of the forecast period.
Key Stakeholders
Injectable Drug Delivery Market Manufacturers
Injectable Drug Delivery Market Distributors/Traders/Wholesalers
Injectable Drug Delivery Market Subcomponent Manufacturers
Industry Association
Downstream Vendors
If you have any special requirements, please let us know and we will offer you the report as you want and also We Provide you Table of Content.
Click Here to Buy this Report@ https://www.persistencemarketresearch.com/checkout/3774
Contact us:
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
No comments:
Post a Comment